Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1

A R de Fougerolles1, S A Stacker, R Schwarting

  • 1Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115.

Insights

Researchers developed monoclonal antibodies to characterize human intercellular adhesion molecule-2 (ICAM-2). They found ICAM-2 is expressed on lymphocytes and endothelium, and plays a role in cell adhesion, though a third LFA-1 ligand may exist.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Human intercellular adhesion molecule-2 (ICAM-2) is a cell surface glycoprotein involved in cell adhesion.
  • Understanding ICAM-2's role is crucial for characterizing immune responses and inflammatory processes.

Purpose of the Study:

  • To further characterize human ICAM-2 using newly developed monoclonal antibodies.
  • To investigate the expression patterns and functional roles of ICAM-2 in cell adhesion and immune cell interactions.

Main Methods:

  • Generation of murine monoclonal antibodies (mAbs) against ICAM-2 transfected cells.
  • Immunoprecipitation and SDS-PAGE to determine ICAM-2 molecular weight.
  • N-glycanase treatment to identify the peptide backbone.
  • Flow cytometry and tissue staining to assess ICAM-2 expression.
  • Cell binding assays and homotypic aggregation assays to evaluate ICAM-2 function in lymphocyte function-associated antigen-1 (LFA-1) mediated adhesion.

Main Results:

  • Two mAbs, CBR-IC2/1 and CBR-IC2/2, were generated.
  • ICAM-2 has a molecular weight of approximately 60,000, with a peptide backbone of 31,000.
  • ICAM-2 is broadly expressed on hematopoietic cell lines and cultured endothelial cells, with expression on resting lymphocytes and monocytes but not neutrophils.
  • ICAM-2 is highly expressed on vascular endothelium.
  • Unlike ICAM-1, ICAM-2 expression shows little induction upon inflammatory stimulation.
  • mAb CBR-IC2/2 inhibited ICAM-2 binding to LFA-1, indicating ICAM-2 is an LFA-1 ligand.
  • ICAM-1 and ICAM-2 together account for LFA-1-dependent binding to endothelium.
  • Homotypic aggregation of JY cells is dependent on ICAM-1 and ICAM-2.
  • A third LFA-1 ligand, distinct from ICAM-1 and ICAM-2, was identified on SKW3 cells.

Conclusions:

  • ICAM-2 is a significant adhesion molecule expressed on endothelium and certain immune cells.
  • ICAM-2, along with ICAM-1, mediates LFA-1-dependent cell adhesion.
  • The study suggests the existence of an additional LFA-1 ligand, highlighting complexity in cell adhesion pathways.

Related Concept Videos

Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Adherens Junctions01:24

Adherens Junctions

Strong contact points between adjacent cells anchor them to each other, forming tissues. Such anchoring junctions are of two types –  adherens junctions and desmosomes. Adherens junctions are abundant in tissues such as  epithelium and endothelium, forming a continuous zone of adhesion called the adhesion belt. In other tissues, such as  heart muscle, they appear as clusters, linking the cells to produce coordinated heart muscle contraction.
Adherens Junctions are Dynamic
The endothelial cells...
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...